Kimera COVID-19 FDA IND Filing
In an effort to mitigate the effects of the current global pandemic and in compliance with the FDA’s mandate of requiring exosome manufacturers to file an investigational new drug (IND)
Stay informed about the latest advancements at Kimera® Labs Inc. and explore the ever-evolving world of exosomes. From scientific breakthroughs to innovative applications, this page is your gateway to the forefront of regenerative medicine and exosome technology.
In an effort to mitigate the effects of the current global pandemic and in compliance with the FDA’s mandate of requiring exosome manufacturers to file an investigational new drug (IND)
At the South Beach Symposium on advances in modern dermatology in Miami Beach, clinical and scientific researchers from Kimera Labs met with a group of well-respected dermatologists and oncologists to
Physicians and scientists have been researching and developing clinical therapeutics using stem cells for the last half century. The clinical results of these stem cell treatments, many of which have
Since its inception, Kimera Labs has been dedicated to the production of the purest mesenchymal stem cell (MSC) exosomes in existence. Kimera Labs produces amniotic fluid exosomes and purified MSC